cardiac hypertrophy_Tg(Myh6-Map2k3*)1Jmol/0

http://metadb.riken.jp/0001625FVBTgMyh6Map2k31JmolTgMyh6Map2k31Jmol0TgMyh6Map2k31Jmol

cardiac hypertrophy_Tg(Myh6-Map2k3*)1Jmol/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 1, Jeffery D Molkentin
  http://metadb.riken.jp/db/mgi_rdf/MGI:3851569

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Myh6-Map2k3*)1Jmol/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Myh6-Map2k3*)1Jmol

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• FVB-Tg(Myh6-Map2k3*)1Jmol

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• cardiac hypertrophy
  http://purl.obolibrary.org/obo/MP_0001625

文献

http://purl.org/net/cito/citesAsAuthority

• Julian C. Braz, et.al., Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling., The Journal of clinical investigation, 2003, 111
  http://rdf.ncbi.nlm.nih.gov/pubmed/12750397